Equities

Abnova Taiwan Corp

4133:TAI

Abnova Taiwan Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)29.05
  • Today's Change0.150 / 0.52%
  • Shares traded31.95k
  • 1 Year change-11.03%
  • Beta--
Data delayed at least 20 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments424368307
Total Receivables, Net7115650
Total Inventory408396416
Prepaid expenses--7.2411
Other current assets, total171.061.79
Total current assets920928786
Property, plant & equipment, net266267278
Goodwill, net------
Intangibles, net706968
Long term investments0.250.5537
Note receivable - long term------
Other long term assets5.24124.30
Total assets1,3561,3751,283
LIABILITIES
Accounts payable151511
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases5.117.206.99
Other current liabilities, total435144
Total current liabilities637363
Total long term debt2.603.690.56
Total debt7.71117.55
Deferred income tax3.785.80--
Minority interest------
Other liabilities, total0.440.538.01
Total liabilities698371
SHAREHOLDERS EQUITY
Common stock606606606
Additional paid-in capital475475475
Retained earnings (accumulated deficit)218224122
Treasury stock - common------
Unrealized gain (loss)(4.95)(4.95)20
Other equity, total(7.25)(6.96)(11)
Total equity1,2861,2921,212
Total liabilities & shareholders' equity1,3561,3751,283
Total common shares outstanding616161
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.